en-GBde-DEja-JPes-ES
MagVenture NEWS

Are you interested in TMS? Stay updated and subscribe to MagVenture NEWS

Read More
Depression treatment for Patients

Do you not respond to antidepressants?
TMS is an effective alternative to medication

Read More
MagVenture Depression Treatment for healthcare professionals

Do you wish to give patients an alternative to antidepressants?

Read More
MagVenture MagPro R30 Stimulator

Magnetic stimulation systems for depression treatment, clinical examination and research

Read More
MagVenture Coils

With 7 different magnetic stimulators and 33 different coils, MagVenture is the ultimate research partner

Read More
< Back
You are here » About  »  News and Events  »  News

Sign Up for the MagVenture Newsletter

Get the latest news about MagVenture and magnetic stimulation directly in your inbox – press on the button below and fill out the form:

MagVenture News

25 Latest Articles
August 04, 2015 

MagVenture receives FDA clearance for TMS depression treatment system

We are pleased to announce that the FDA has cleared our MagVita TMS Therapy system for the treatment of Major Depressive Disorder.

Low operating costs - due to no per-use fee - together with an easy administration and equal efficacy rates as other cleared devices makes the MagVita TMS Therapy system the optimal choice for both doctors and patients.

The MagVita TMS Therapy System is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode.

The MagVita TMS Therapy system was the first system to be cleared in the EU (in 2011) and has a proven track-record of treatment efficacy, usability, and quality.

Read the interviews with current users of the MagVita TMS Therapy system in our Newsletter, where you will also find exciting articles on pioneering research with TMS.

MagVenture is a medical device company specializing in non-invasive magnetic stimulation systems for depression treatment as well as for clinical examination and research in the areas of neurophysiology, neurology, cognitive neuroscience, rehabilitation, and psychiatry.

MagVenture strives to be the most dynamic and innovative supplier of transcranial magnetic stimulation solutions. Market feedback and inputs are continuously incorporated in our product development, and many "first mover" features and improvements have over the years been added in response to leading doctors' and researchers' ideas and requests. 

Related Images

  • MagVenture receives FDA clearance for TMS depression treatment system

Researchers

Researcher

Healthcare Professionals

Healthcare Professional

Products

Download

Download Brochure